Bill Commons

CA AB 2302

Status unknown

Food safety: infant formula.

California · 2025-2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did CA AB 2302 pass?

The current status of CA AB 2302 is not known from the official record. Latest recorded action (2026-07-01): In committee: Set, first hearing. Hearing canceled at the request of author.

What is CA AB 2302 about?

Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of various subjects relating to the manufacturing, processing, labeling, advertising, and sale of food, drugs, and cosmetics, under the administration and enforcement of the State Department of Public Health. A violation of these provisions is punishable as a misdemeanor. This bill would require a manufacturer of infant formula for sale or distribution in this state to test its final infant formula product for arsenic, cadmium, lead, and mercury at least once per month. The bill also would, commencing on January 1, 2028, require a brand owner, as defined, to provide information to consumers on its internet website or package label regarding specific information about its infant formula that includes, among other things, certain test results for arsenic, cadmium, lead, and mercury. The bill would specifically prohibit a person from selling in the state or manufacturing, delivering, holding, or offering for sale in the state any infant formula that does not comply with these requirements. The bill would require the manufacturer and brand owner to provide test results to the department upon request, as specified. By expanding the requirements relating to infant formula under the Sherman Food, Drug, and Cosmetic Law, the violation of which would be a crime, this bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.

Who sponsors CA AB 2302?

Celeste Rodriguez is the primary sponsor of CA AB 2302, joined by 3 cosponsors.

Description

Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of various subjects relating to the manufacturing, processing, labeling, advertising, and sale of food, drugs, and cosmetics, under the administration and enforcement of the State Department of Public Health. A violation of these provisions is punishable as a misdemeanor. This bill would require a manufacturer of infant formula for sale or distribution in this state to test its final infant formula product for arsenic, cadmium, lead, and mercury at least once per month. The bill also would, commencing on January 1, 2028, require a brand owner, as defined, to provide information to consumers on its internet website or package label regarding specific information about its infant formula that includes, among other things, certain test results for arsenic, cadmium, lead, and mercury. The bill would specifically prohibit a person from selling in the state or manufacturing, delivering, holding, or offering for sale in the state any infant formula that does not comply with these requirements. The bill would require the manufacturer and brand owner to provide test results to the department upon request, as specified. By expanding the requirements relating to infant formula under the Sherman Food, Drug, and Cosmetic Law, the violation of which would be a crime, this bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.

Introduced
2026-03-25
Latest action
2026-07-01 — In committee: Set, first hearing. Hearing canceled at the request of author.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Celeste Rodriguezauthor
  • Gipsonprincipal coauthor
  • Calderoncoauthor
  • Leecoauthor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-07-01

    In committee: Set, first hearing. Hearing canceled at the request of author.

  2. 2026-06-25

    From committee: Do pass and re-refer to Com. on E.Q. (Ayes 9. Noes 0.) (June 24). Re-referred to Com. on E.Q.

    committee-passage,committee-passage-favorable,referral-committee

  3. 2026-06-15

    From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.

    amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee

  4. 2026-06-10

    Referred to Coms. on HEALTH and E.Q.

    referral-committee

  5. 2026-05-28

    In Senate. Read first time. To Com. on RLS. for assignment.

    reading-1,referral-committee

  6. 2026-05-27

    Read third time. Passed. Ordered to the Senate. (Ayes 69. Noes 0.)

    passage,reading-1,reading-3

  7. 2026-05-27

    Read third time. Passed. Ordered to the Senate. (Ayes 69. Noes 0. Page 5481.)

    passage,reading-1,reading-3

  8. 2026-05-19

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  9. 2026-05-18

    Read second time and amended. Ordered returned to second reading.

    amendment-passage,reading-1,reading-2

  10. 2026-05-14

    Joint Rule 62(a), file notice suspended. (Page 5030.)

  11. 2026-05-14

    From committee: Amend, and do pass as amended. (Ayes 12. Noes 0.) (May 14).

    amendment-introduction,amendment-passage,committee-passage

  12. 2026-05-13

    In committee: Set, first hearing. Referred to APPR. suspense file.

    referral-committee

  13. 2026-04-20

    Re-referred to Com. on APPR.

    referral-committee

  14. 2026-04-16

    Read second time and amended.

    amendment-passage,reading-1,reading-2

  15. 2026-04-15

    From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 4. Noes 1.) (April 14).

    amendment-introduction,amendment-passage,committee-passage,referral-committee

  16. 2026-04-06

    Re-referred to Com. on E.S & T.M.

    referral-committee

  17. 2026-03-26

    Read second time and amended.

    amendment-passage,reading-1,reading-2

  18. 2026-03-25

    From committee: Amend, and do pass as amended and re-refer to Com. on E.S & T.M. (Ayes 13. Noes 0.) (March 24).

    amendment-introduction,amendment-passage,committee-passage,referral-committee

  19. 2026-03-09

    Referred to Coms. on HEALTH and E.S & T.M.

    referral-committee

  20. 2026-02-20

    From printer. May be heard in committee March 22.

  21. 2026-02-19

    Read first time. To print.

    reading-1

Versions

  • 02/19/26 - Introduced — 2026-02-19Compare
  • 03/26/26 - Amended Assembly — 2026-03-26Compare
  • 04/16/26 - Amended Assembly — 2026-04-16Compare
  • 05/18/26 - Amended Assembly — 2026-05-18Compare
  • 06/15/26 - Amended Senate — 2026-06-15Compare
  • AB2302Compare
  • (document, no version)Compare

Documents

Votes

  • Do pass as amended and be re-referred to the Committee on [Environmental Safety and Toxic Materials]

    2026-03-24 · pass · 13-0

    Member-level votes (16)
    • Caloza: yes
    • Stefani: yes
    • Pacheco: yes
    • Addis: yes
    • Schiavo: yes
    • Carrillo: yes
    • Patel: yes
    • Mark González: yes
    • Sanchez: yes
    • Aguiar-Curry: yes
    • Rogers: yes
    • Sharp-Collins: yes
    • Bonta: yes
    • Johnson: other
    • Chen: other
    • Patterson: other

  • Do pass as amended and be re-referred to the Committee on [Appropriations]

    2026-04-14 · pass · 4-1

    Member-level votes (7)
    • Bauer-Kahan: yes
    • Papan: yes
    • Lee: yes
    • Connolly: yes
    • Ellis: no
    • Castillo: other
    • McKinnor: other

  • Do pass as amended.

    2026-05-14 · pass · 12-0

    Member-level votes (15)
    • Dixon: yes
    • Krell: yes
    • Sharp-Collins: yes
    • Wicks: yes
    • Pacheco: yes
    • Caloza: yes
    • Fong: yes
    • Calderon: yes
    • Solache: yes
    • Pellerin: yes
    • Aguiar-Curry: yes
    • Mark González: yes
    • Tangipa: other
    • Ta: other
    • Hoover: other

  • AB 2302 Celeste Rodriguez Assembly Third Reading By LEE

    2026-05-28 · pass · 69-0

    Member-level votes (80)
    • Bennett: yes
    • Connolly: yes
    • Stefani: yes
    • Rivas: yes
    • Davies: yes
    • Michelle Rodriguez: yes
    • Schiavo: yes
    • Ávila Farías: yes
    • Papan: yes
    • Fong: yes
    • Calderon: yes
    • Sharp-Collins: yes
    • Aguiar-Curry: yes
    • Hart: yes
    • Ramos: yes
    • Addis: yes
    • Bains: yes
    • Elhawary: yes
    • Boerner: yes
    • Ward: yes
    • Alvarez: yes
    • Flora: yes
    • Rogers: yes
    • Chen: yes
    • Soria: yes
    • Harabedian: yes
    • Jeff Gonzalez: yes
    • Lee: yes
    • Jackson: yes
    • Zbur: yes
    • Wicks: yes
    • Bonta: yes
    • Hoover: yes
    • Pellerin: yes
    • Petrie-Norris: yes
    • Carrillo: yes
    • Berman: yes
    • Valencia: yes
    • Gabriel: yes
    • Caloza: yes
    • Wilson: yes
    • Bryan: yes
    • Ahrens: yes
    • Bauer-Kahan: yes
    • Alanis: yes
    • Blanca Rubio: yes
    • Haney: yes
    • Arambula: yes
    • Sanchez: yes
    • Gipson: yes
    • Lowenthal: yes
    • Quirk-Silva: yes
    • Nguyen: yes
    • DeMaio: yes
    • Dixon: yes
    • Krell: yes
    • Wallis: yes
    • Patel: yes
    • Ortega: yes
    • Mark González: yes
    • Garcia: yes
    • Solache: yes
    • Kalra: yes
    • Schultz: yes
    • Gallagher: yes
    • Pacheco: yes
    • Ransom: yes
    • Irwin: yes
    • Muratsuchi: yes
    • Johnson: other
    • Macedo: other
    • Celeste Rodriguez: other
    • McKinnor: other
    • Castillo: other
    • Hadwick: other
    • Tangipa: other
    • Patterson: other
    • Ellis: other
    • Lackey: other
    • Ta: other

  • Do pass, but first be re-referred to the Committee on [Environmental Quality]

    2026-06-24 · pass · 9-0

    Member-level votes (11)
    • Pérez: yes
    • Gonzalez: yes
    • Weber Pierson: yes
    • Caballero: yes
    • Smallwood-Cuevas: yes
    • Rubio: yes
    • Durazo: yes
    • Padilla: yes
    • Menjivar: yes
    • Grove: other
    • Valladares: other

Related bills

No related bills recorded for this bill.

Official source

http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202520260AB2302

Attribution

Data from openstates_api_sync, retrieved 2026-10-17T19:29:50.497592Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changesStatus and relationship changes

Session-wide evidence can include changes to other bills:

Bulk imports for this sessionSession dates and activity

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 2302. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.